Par Drugs and Chemicals Limited

271.1

INR
+2.10(+0.78%)
As of November 14, 2024 10:00:00 AM

Par Drugs and Chemicals Limited Share Price Information

24 hour Low and High

Low: 270.1
High: 277.7

All time High

311.75

Price Change 1h

+₹0.95 +0.35%

Price Change 1d

+₹0.95 +0.35%

Price Change 1w

+₹-20.85 +-7.14%

Par Drugs and Chemicals Limited Market Information

Exchange

NSE

Market Cap

360.78 Cr

About Par Drugs and Chemicals Limited Share

Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, magnesium aluminometasilicate, magnesium aluminosilicate-USP, magnesium oxide light, magnesium oxide heavy, magnesium aluminium hydrate, hydrotalcite, and synthetic aluminium silicate. It offers fine chemicals, such as precipitated silica, sodium aluminium silicate, amorphous aluminium hydroxide, PARSIL-HT, PAR ADD OP, MagSil OF, FlowSil, aluminium hydroxide magnesium carbonate co-dried gel, magnesium aluminium silicate hydrated (pharma), and magnesium aluminium silicate hydrated (agro). It exports its products to Germany, the United Kingdom, Bangladesh, Iran, the United Arab Emirates, Indonesia, Japan, South Korea, and internationally. Par Drugs and Chemicals Limited was founded in 1982 and is based in Vadodara, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

122

CEO

Mr. Jignesh Vallabhbhai Savani

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Par Drugs & Chemicals Ltd Hits All-Time High, Outperforms Sector and Market
  • Is Par Drugs and Chemicals Limited's (NSE:PAR) Recent Stock Performance Tethered To Its Strong Fundamentals?
  • Breakout stocks to buy or sell: FSL to Indian Bank — Sumeet Bagadia recommends five shares to buy today | Stock Market News
  • Par Drugs Standalone September 2024 Net Sales at Rs 34.66 crore, up 33.88% Y-o-Y
  • Pharma stock jumps 12% after company’s net profit increases 240% QoQ

FAQs

Par Drugs and Chemicals Limited

271.1

INR
+2.10(+0.78%)
As of November 14, 2024 10:00:00 AM

Par Drugs and Chemicals Limited Share Price Information

24 hour Low and High

Low: 270.1
High: 277.7

All time High

311.75

Price Change 1h

+₹0.95 +0.35%

Price Change 1d

+₹0.95 +0.35%

Price Change 1w

+₹-20.85 +-7.14%

Par Drugs and Chemicals Limited Market Information

Exchange

NSE

Market Cap

360.78 Cr

About Par Drugs and Chemicals Limited Share

Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, magnesium aluminometasilicate, magnesium aluminosilicate-USP, magnesium oxide light, magnesium oxide heavy, magnesium aluminium hydrate, hydrotalcite, and synthetic aluminium silicate. It offers fine chemicals, such as precipitated silica, sodium aluminium silicate, amorphous aluminium hydroxide, PARSIL-HT, PAR ADD OP, MagSil OF, FlowSil, aluminium hydroxide magnesium carbonate co-dried gel, magnesium aluminium silicate hydrated (pharma), and magnesium aluminium silicate hydrated (agro). It exports its products to Germany, the United Kingdom, Bangladesh, Iran, the United Arab Emirates, Indonesia, Japan, South Korea, and internationally. Par Drugs and Chemicals Limited was founded in 1982 and is based in Vadodara, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

122

CEO

Mr. Jignesh Vallabhbhai Savani

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Par Drugs & Chemicals Ltd Hits All-Time High, Outperforms Sector and Market
  • Is Par Drugs and Chemicals Limited's (NSE:PAR) Recent Stock Performance Tethered To Its Strong Fundamentals?
  • Breakout stocks to buy or sell: FSL to Indian Bank — Sumeet Bagadia recommends five shares to buy today | Stock Market News
  • Par Drugs Standalone September 2024 Net Sales at Rs 34.66 crore, up 33.88% Y-o-Y
  • Pharma stock jumps 12% after company’s net profit increases 240% QoQ

FAQs